“Mesoblast intends to generate in the coming months new potency assay data for RYONCIL showing that the product used during pediatric Phase 3 trial MSB-GVHD001 WAS standardized as to its identity, strength, quality, purity, and dosage form to give significance to the results of the investigation as described in the Code of Federal Regulations for adequate and well- controlled studies (21 CFR 314.126), and that commercial batches made for the pediatric indication will meet the same standard.”
Looks like SI is getting the sh*}s with FDA. Tired of getting kicked post to post.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Type A Meeting with FDA
Ann: Mesoblast Type A Meeting with FDA, page-15
-
- There are more pages in this discussion • 560 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 280000 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 280000 | 1.065 |
5 | 149799 | 1.060 |
9 | 124023 | 1.055 |
14 | 191984 | 1.050 |
8 | 134232 | 1.045 |
Price($) | Vol. | No. |
---|---|---|
1.070 | 2000 | 1 |
1.075 | 19000 | 2 |
1.080 | 48905 | 3 |
1.085 | 28905 | 1 |
1.090 | 61845 | 5 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |